FFMI fastPACE Fall 2017 Teaching Team

Therapeutic 1

Deborah Ladenheim

Title: Mentor-in-Residence
Phone: 734.615.0423
E-mail: dladen@umich.edu

Deborah has worked in the pharmaceutical industry for over 25 years in both small biotechnology companies as well as big pharma as a regulatory strategist. She currently owns her own consulting business where she advises companies in the US and abroad. Previously, Deborah was a senior consultant at Catalyst Regulatory Services and served as Vice President of Regulatory Affairs at Athersys Inc, a biotechnology company focused on developing novel allogeneic stem cell therapies for the treatment of indications with unmet medical need. Prior to Athersys, she was Vice President of Regulatory Affairs at Avidimer Inc., a startup biotechnology company developing nanotherapeutic solutions to drug delivery and worked at Pfizer Inc and Glaxo in positions of increasing responsibility up to Global Regulatory Leader. She holds a B. Pharm. in Pharmacy from the University of Wales, UK and a Ph.D. in Pharmacy from the University of Brighton, UK.

Stefan Koehler

Title: Senior Licensing Specialist, Health Technologies
E-mail: shkohler@umich.edu

Stefan Koehler collaborates with faculty and researchers from various areas including the School of Medicine to protect and commercialize intellectual property developed at the University of Michigan.

Prior to joining the Office of Technology Transfer, Stefan worked in various roles in business development, technology licensing, consulting, and entrepreneurship education in industry and academia including with Epicentre Biotechnologies (acquired by Illumina Corporation), KPMG Transaction Services, and the Entrepreneurship Centers of the University of Wisconsin – Madison, and the University of Munich.

Stefan holds a BS and MS in Molecular Biology with a minor in Patent Law from the University of Munich and an MBA from the University of Wisconsin, Madison.

Michelle Larkin

Title: MTRAC for Life Sciences Tech Mining Specialist
Phone: 734-615-7886
E-mail: michcote@umich.edu

Michelle is a biomedical engineer who has worked in the start-up medical device world, and most recently as a key project manager for the Coulter Translational Research Partnership Program. Prior to that, she was with the Michigan Pediatric Device Consortium (M-PED). She’s a graduate twice over from the U-M College of Engineering in Biomedical Engineering.

Therapeutic 2

Bradley Martin, Ph.D.

Bradley Martin

Title: MTRAC for Life Sciences Commercialization Program Director
Phone: 734-936-8577
E-mail: bradmart@umich.edu

Brad comes to the MTRAC team with 15-plus years of experience in the development of drugs and biologics, and particular expertise in preclinical development and translational research in the field of cardiovascular physiology and regenerative medicine. Much of his career has focused on the development of stem cell therapies for the treatment of myocardial infarction and heart failure.

He has considerable experience in leading cross-functional project teams, and has transitioned therapies from product concept through preclinical development, IND approval and eventual clinical trial. Prior to leading MTRAC, Brad served as a Mentor in Residence for the U-M Tech Transfer Office, was the Director of Product Development at Aastrom Biosciences, and the Director of Cardiac Research at Osiris Therapeutics Inc. He also spent several years as a Principal Scientist with Pfizer’s Esperion Division, studying the anti-atherosclerotic properties of ApoA-I Milano, and other novel peptides.

He received in Ph.D. in Physiology in 1993 from the University of Michigan, and completed post-doctoral fellowships in the departments of Cardiothoracic Surgery and Physiology at the University of Wisconsin.

Sara Johnson

Title: MTRAC for Life Sciences Tech Mining Specialist
Phone: 734 764-5598
E-mail: johnssar@med.umich.edu

Previously a biomedical scientist, Sara also has significant experience in academic technology transfer and commercialization. Prior to joining FFMI, she was a commercialization associate at OhioHealth, where she helped innovators navigate the commercial pathway to bring their medical technologies to market. Sara earned a BS in Biology from Kent State University and a PhD in Biomedical Science from The Ohio State University.


David Olson

Title: Mentor-in-Residence
Phone: 734.764.9117
E-mail: davidols@umich.edu

Dr. Olson has more than 18 years of experience in building life science companies, product development, intellectual property management, business development and venture financing. He has co-founded 6 biotech start-ups, managed other early-stage businesses, and authored business plans backed by more than $61M in capital. Most recently he was co-founder and CEO of Swift Biosciences Inc. where he led the creation, funding and development of the company for six years. During that time Swift invented and brought to market multiple new technologies for genetic analysis and Next Generation Sequencing. Prior to Swift, Dr. Olson was a founding member of Accuri Cytometers Inc. (acquired by Becton Dickinson in 2011), where he was responsible for creating Accuri’s product vision and played a central role in all aspects of corporate strategy. Dr. Olson received his doctorate in Molecular Biology from Princeton University, and completed a postdoctoral fellowship at the University of California, San Francisco.

Kate Remus

Title: Mentor-in-Residence
E-mail: kateremu@umich.edu

Kate Remus has 15+ years of strategy, general management and operating experience in medical device and life sciences businesses.

Most recently, Kate launched Halley Orthopedics, a medical device startup disrupting the $7B knee replacement market with patented technology that dramatically reduces cost while transforming the patient experience and improving treatment outcomes. The company was Automation Alley’s 2015 Startup of the Year.

Previously, Kate was a Principal at Monitor Group, a global corporate-strategy consulting firm, where she helped clients find and unlock new sources of growth. Kate has worked extensively in the retail, biotech and pharma, with a focus on new business development.

Kate earned a Bachelor of Science with honors from Georgetown University (International Business & Computer Science) and was a Dean’s Fellow and Falls Prize recipient at the University of North Carolina Chapel Hill (MBA, Healthcare Entrepreneurship & Finance). A native of Southeast, Michigan, Kate has traveled and worked extensively across Europe, South America and Asia and is excited to be anchored closer to home. Kate lives in Brighton, MI and has a retreat in Harbor Springs where she enjoys golfing, kayaking and skiing.

Janani Ramaswamy

Title: Licensing Specialist, Medical Devices
Phone: 734.763.9081
E-mail: jananir@umich.edu

Janani Ramaswamy just joined us from the Henry Ford Health System where she was a Licensing Associate and managed a portfolio of medical devices, biotechnology and digital healthcare inventions. Janani has a PhD in biomedical engineering from U-M and a B.S. in Biotechnology from Vellore Institute of Technology in India. Janani also worked as a Tech Transfer Fellow in our office in 2013-2014. Janani is one of our new Licensing Specialists with a focus in medical devices and other technologies.

Health IT

Drew Bennett

Title: Associate Director, Software, Mobile and Digital Technologies
Phone: 734.615.4004
E-mail: andbenne@umich.edu

Drew collaborates with faculty and researchers from various areas including the College of Engineering, School of Medicine and others to protect and commercialize intellectual property developed at the University of Michigan. His focus is on the development and commercialization of software, mobile and digital based technologies.

Prior to joining the Office of Technology Transfer, Drew worked in a variety of Senior Software Product Development and Management roles with Firstlogic (SAP), Valassis Relationship Marketing Systems, ePrize and ForeSee. Drew started his career as Registered Respiratory Therapist (RRT) working in Trauma and Neuro Intensive care.

Drew holds a BS from Western Michigan University and an MBA from the University of Detroit.

Jessica Soulliere

Title: Senior Licensing Specialist, Digital Technologies
Phone: 734.647.9926
E-mail: jdsoul@umich.edu

Jessica collaborates with faculty and researchers throughout the University of Michigan to protect and commercialize intellectual property. She is responsible for software, mobile and digital technologies. Jessica also engages with faculty and staff in early stage ideas utilizing the Digital Discovery Process. This process is designed to help faculty solidify early stage ideas for digital inventions.

Prior to joining the University of Michigan, Jessica worked in various Software Development and Management roles including Program Management, Quality Assurance and Business Analysis with ePrize, Micros Inc. (Oracle), and Valassis.

Dave Repp

Title: Assistant Director, Venture Center
Phone: 734.936.1955
E-mail: drepp@umich.edu

As Senior Venture Specialist, Dave focuses on the creation of life science start-up companies and business opportunities based on technologies discovered and developed at the University of Michigan. He has over 15 years of experience in research commercialization, new venture creation, and business consulting in the life sciences and high tech industries.

Before joining the Venture Center, Dave was President and COO of Gema Diagnostics, a venture-backed molecular diagnostics company seeking to improve clinical outcomes in in vitro fertilization. Prior to Gema, he helped launch and was Vice President of University of Michigan spin-out, Avidimer Therapeutics. He consulted at ANGLE Technology, a venture investment and management consulting firm focused on life sciences and high tech opportunities in the US and UK, and Deloitte Consulting where he was on the Strategic Advisory Team for the firm’s High Tech Industry Practice.

Dave earned his MBA (Samuel Zell Scholar) from the Stephen M. Ross School of Business at the University of Michigan and BS and MS degrees in Mechanical Engineering from the University of Michigan.

October 13, 2017